ThalysBio hemostasis reagents have a wide range of customer applications with market-proven quality and excellent performance. Recently, our products including APTT, PT, TT, FIB and AT-III coagulation reagents have been evaluated by an internationally renowned third-party quality control vendor, Landau, UK, and provide three levels of quality control and assignment of level 1, level 2, and level 3. Tables are used by users. ThalysBio hemostasis reagent is the first domestic manufacturer of hemostasis diagnostic reagents to enter the internationally renowned third-party quality control group.

Founded in 2002, ThalysBio is a new biomedical high-tech enterprise dedicated to the research, development, production and sales of in vitro diagnostic reagents. As the company with the most complete hemostasis test reagents in China, we have successfully listed the routine hemostasis test reagents APTT, PT, TT, FIB, D-dimer, FDP and AT-III, and also developed the special six items: PLG, PAI, α2-PI and other fibrinolytic test reagents, lupus anticoagulant screening (LA1), confirmatory diagnosis (LA2) reagents, as well as anticoagulant drug monitoring reagents (Anti-Xa) and the supporting calibration and quality control. Drug monitoring reagents (Anti-Xa), as well as supporting calibration and quality control.

Randox Laboratories Ltd. (Randox) is the largest manufacturer of diagnostic products in the UK.
Randox QCs are categorized into fixed-value QCs and non-fixed-value QCs. Fixed-value QCs are supplied with a target value table at the factory, and the statistical data of the target value comes from at least 5,000 laboratories around the world, which provides users with the most objective and accurate third-party QC target value, and can evaluate the precision and accuracy of the experimental system at the same time.

ThalysBio with high quality products and services, professional knowledge and technology, to solve the most concerned problems of patients, doctors and partners!